Detalles de la búsqueda
1.
A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection.
Clin Infect Dis;
71(5): 1255-1262, 2020 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769793
2.
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.
JNCI Cancer Spectr;
4(2): pkz093, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32328561
Resultados
1 -
2
de 2
1
Próxima >
>>